(Q36214876)

12 August 2017

1 reference

title

Can we justify goal blood pressure of <140/90 mm Hg in most hypertensives? (English)

1 reference

12 August 2017

Raymond R Townsend

1

1 reference

12 August 2017

1 August 2005

1 reference

Current Hypertension Reports

12 August 2017

1 reference

12 August 2017

7

1 reference

12 August 2017

257-264

1 reference

12 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-005-0022-3

12 August 2017

0 references

cites work

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-005-0022-3

Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-005-0022-3

Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population

21 January 2018

1 reference

12 December 2020

Improvement of blood pressure control in a hypertension clinic: a 10-year follow-up study

1 reference

12 December 2020

Ticrynafen's withdrawal from the market

1 reference

12 December 2020

Improving control of hypertension by an integrated approach -- results of the 'Manage it well!' programme

1 reference

12 December 2020

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

1 reference

12 December 2020

Characteristics of patients with uncontrolled hypertension in the United States.

1 reference

12 December 2020

Risk factors for uncontrolled hypertension in Italy.

1 reference

12 December 2020

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia

1 reference

12 December 2020

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

12 December 2020

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

12 December 2020

Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative Study

1 reference

12 December 2020

A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension

1 reference

12 December 2020

Association between cardiovascular outcomes and antihypertensive drug treatment in older women

1 reference

12 December 2020

Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment

1 reference

12 December 2020

Advanced glycation end-product cross-link breakers. A novel therapeutic pathway for cardiovascular disease

1 reference

12 December 2020

The effects of antihypertensive therapy on the quality of life

1 reference

12 December 2020

Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension

1 reference

12 December 2020

An overview of the meta-analyses of the hypertension treatment trials

1 reference

12 December 2020

Hypertension treatment and control in five European countries, Canada, and the United States

1 reference

12 December 2020

Hypertension management and control in primary care: a study of 20 practices in 14 states.

1 reference

12 December 2020

Blood pressure control and factors predicting control in a treatment-compliant male veteran population

1 reference

12 December 2020

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial

1 reference

12 December 2020

Carcinogenicity of antihypertensive therapy

1 reference

12 December 2020

Quality of care for hypertension in the United States

1 reference

12 December 2020

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

1 reference

12 December 2020

Systolic blood pressure and mortality

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension.

1 reference

12 December 2020

Blood pressure control and physician management of hypertension in hospital hypertension units in Spain.

1 reference

12 December 2020

Evidence-based medicine and treatment of hypertension in women: results of trials.

1 reference

12 December 2020

The ethics of using placebo in hypertension clinical trials.

1 reference

12 December 2020

How important is optimal blood pressure control?

1 reference

12 December 2020

Clinician awareness of adherence to hypertension guidelines.

1 reference

12 December 2020

Update on the management of hypertension: recent clinical trials and the JNC 7.

1 reference

12 December 2020

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

12 December 2020

Demographic and clinical characteristics of hypertensive patients in the internal medicine outpatient clinic of a university hospital in Rio de Janeiro.

1 reference

12 December 2020

Prehypertension: a possible target for antihypertensive medication

1 reference

12 December 2020

High prevalence and poor control of hypertension in primary care: cross-sectional study.

1 reference

12 December 2020

Is diuretic therapy associated with an increased risk of colon cancer?

1 reference

12 December 2020

Determinants of JNC VI guideline adherence, intensity of drug therapy, and blood pressure control by race and ethnicity

1 reference

12 December 2020

The withdrawal of mibefradil (Posicor)

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Update on unethical use of placebos in randomised trials

1 reference

12 December 2020

Treatment of elderly hypertensive patients with a delayed-release verapamil formulation in a community-based trial

1 reference

12 December 2020

One-year study of felodipine or placebo for stage 1 isolated systolic hypertension

1 reference

12 December 2020

Hypertension management and control among English adults aged 65 years and older in 2000 and 2001.

1 reference

12 December 2020

Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group

1 reference

12 December 2020

Diuretics and renal cell cancer

1 reference

12 December 2020

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

12 December 2020

Blood pressure control in Spanish hypertensive patients in Primary Health Care Centres. PRESCAP 2002 Study

1 reference

12 December 2020

Reserpine and breast cancer

1 reference

12 December 2020

Narrowing the gap in hypertension: effectiveness of a complex antihypertensive program in the elderly

1 reference

12 December 2020

Use of calcium channel blockers and breast carcinoma risk in postmenopausal women

1 reference

12 December 2020

Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid

1 reference

12 December 2020

The Hypertension Optimal Treatment study and the importance of lowering blood pressure.

1 reference

12 December 2020

Reflections on hypertension control rates: a message from the director of the National Heart, Lung, and Blood Institute

1 reference

12 December 2020

Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line comb

1 reference

12 December 2020

Relation between blood pressure and mortality: is there a threshold?

1 reference

12 December 2020

10.1007/S11906-005-0022-3

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16061043